Literature DB >> 9850335

Differences in p53 and Bcl-2 expression in relation to cell proliferation during the development of human embryos.

V Lichnovský1, Z Kolár, P Murray, A Hlobilková, D Cernochová, E Pospísilová, B Vojtĕsek, R Nenutil.   

Abstract

AIMS: To study the patterns of p53 and Bcl-2 expression in relation to cell proliferation during human embryogenesis in order to help elucidate their potential roles in the regulation of cell proliferation and apoptosis during morphogenesis.
METHODS: Immunohistochemistry for p53, Bcl-2, and proliferating cell nuclear cell antigen (PCNA) proteins was performed, using a variety of monoclonal antibodies, on paraffin was embedded sections of tissues from 68 human embryos and fetuses of between 4 and 30 weeks gestation.
RESULTS: Positive relations between sites of proliferative activity (as detected by PCNA expression) and p53 expression were found in the kidney, early developmental stages of intestine and lungs, liver, pancreas, heart, and in embryonic osteoblasts. On the other hand, positive relations between proliferative activity and Bcl-2 expression were found in the gonads, adrenal glands, in the cells of the dental lamina, hair follicles, syncytiotrophoblast, chondrocytes, and more advanced stages of intestinal development. In tissues of the central nervous system, p53 and Bcl-2 were co-expressed at the same sites but there was an inverse relation between p53/Bcl-2 expression and proliferative activity.
CONCLUSIONS: These data suggest that p53 and Bcl-2 have tissue specific and stage specific functions during embryogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850335      PMCID: PMC395624          DOI: 10.1136/mp.51.3.131

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  31 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

Review 2.  p53 function and dysfunction.

Authors:  B Vogelstein; K W Kinzler
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

3.  Expression of bcl-2 in fetal tissues suggests a role in morphogenesis.

Authors:  D P LeBrun; R A Warnke; M L Cleary
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

4.  p53 is required for radiation-induced apoptosis in mouse thymocytes.

Authors:  S W Lowe; E M Schmitt; S W Smith; B A Osborne; T Jacks
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

5.  Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents.

Authors:  M Fritsche; C Haessler; G Brandner
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

6.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

7.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

8.  High levels of p53 protein in UV-irradiated normal human skin.

Authors:  P A Hall; P H McKee; H D Menage; R Dover; D P Lane
Journal:  Oncogene       Date:  1993-01       Impact factor: 9.867

9.  An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.

Authors:  B Vojtĕsek; J Bártek; C A Midgley; D P Lane
Journal:  J Immunol Methods       Date:  1992-07-06       Impact factor: 2.303

10.  Expression of p53 during mouse embryogenesis.

Authors:  P Schmid; A Lorenz; H Hameister; M Montenarh
Journal:  Development       Date:  1991-11       Impact factor: 6.868

View more
  8 in total

1.  Delta40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs.

Authors:  Erica Ungewitter; Heidi Scrable
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

2.  Role of mitotic, pro-apoptotic and anti-apoptotic factors in human kidney development.

Authors:  Dominko Carev; Dragan Krnić; Marijan Saraga; Damir Sapunar; Mirna Saraga-Babić
Journal:  Pediatr Nephrol       Date:  2006-03-28       Impact factor: 3.714

3.  Expression of the hMLH1 and hMSH2 proteins in normal tissues: relationship to cancer predisposition in hereditary non-polyposis colon cancer.

Authors:  Pavlína Plevová; Eva Sedláková; Jana Zapletalová; Anna Krepelová; Petra Skýpalová; Zdenek Kolár
Journal:  Virchows Arch       Date:  2004-12-10       Impact factor: 4.064

4.  Effect of potential role of p53 on embryo development arrest induced by H2O2 in mouse.

Authors:  De-Bao Hu; Zhong-Shu Li; Ihsan Ali; Li-Jie Xu; Nan-Zhu Fang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-01-27       Impact factor: 2.416

5.  Developmental patterns of caspase-3, bax and bcl-2 proteins expression in the human spinal ganglia.

Authors:  Katarina Vukojevic; Dominko Carev; Damir Sapunar; Danijel Petrovic; Mirna Saraga-Babic
Journal:  J Mol Histol       Date:  2008-04-16       Impact factor: 2.611

6.  Markers of cellular senescence are elevated in murine blastocysts cultured in vitro: molecular consequences of culture in atmospheric oxygen.

Authors:  Alexandra Meuter; Lisa-Marlen Rogmann; Boris J Winterhoff; Tamar Tchkonia; James L Kirkland; Dean E Morbeck
Journal:  J Assist Reprod Genet       Date:  2014-08-10       Impact factor: 3.412

7.  Immunohistochemical analysis of apoptosis-related proteins in human embryonic and fetal pancreatic tissues.

Authors:  H Kobayash; R Doi; R Hosotani; Y Miyamoto; T Koshiba; K Fujimoto; J Ida; S Tsuji; S Nakajima; M Kawaguchi; K Shiota; M Imamura
Journal:  Int J Pancreatol       Date:  2000-04

Review 8.  Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness.

Authors:  David J Olivos; Lindsey D Mayo
Journal:  Int J Mol Sci       Date:  2016-11-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.